Crossmark

CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer

Crossref DOI link: https://doi.org/10.1186/s12967-018-1673-6

Published Online: 2018-10-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pu, Ning

Zhao, Guochao

Yin, Hanlin

Li, Jian-ang

Nuerxiati, Abulimiti

Wang, Dansong

Xu, Xuefeng

Kuang, Tiantao

Jin, Dayong

Lou, Wenhui

Wu, Wenchuan http://orcid.org/0000-0002-8408-885X
Funding

Funding for this research was provided by:

China Scholarship Council (201806100118)

National Natural Science Foundation of China (81272731)

Shanghai Pujiang Program (16PJD013)
License Information

Text and Data Mining valid from 2018-10-25
More Information

Article History

Received: 15 June 2018

Accepted: 19 October 2018

First Online: 25 October 2018